These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 30149665)

  • 1. Triterpene Acid (
    Choi HS; Kim SL; Kim JH; Deng HY; Yun BS; Lee DS
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30149665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol derived from aronia juice through lactic acid bacteria fermentation inhibits breast cancer stem cell formation via modulation Stat3/IL-6 signaling pathway.
    Choi HS; Kim JH; Kim SL; Deng HY; Lee D; Kim CS; Yun BS; Lee DS
    Mol Carcinog; 2018 Nov; 57(11):1467-1479. PubMed ID: 29964299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Betavulgarin Isolated from Sugar Beet (
    Liu R; Choi HS; Zhen X; Kim SL; Kim JH; Ko YC; Yun BS; Lee DS
    Molecules; 2020 Jun; 25(13):. PubMed ID: 32630026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coriolic Acid (13-(
    Ko YC; Choi HS; Kim JH; Kim SL; Yun BS; Lee DS
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33114669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caudatin Isolated from
    Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Ko YC; Yun BS; Lee DS
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32570844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machilin D, a Lignin Derived from Saururus chinensis, Suppresses Breast Cancer Stem Cells and Inhibits NF-κB Signaling.
    Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Yun BS; Lee DS
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis.
    Li W; Ma H; Zhang J; Zhu L; Wang C; Yang Y
    Sci Rep; 2017 Oct; 7(1):13856. PubMed ID: 29062075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Koenimbin, a natural dietary compound of Murraya koenigii (L) Spreng: inhibition of MCF7 breast cancer cells and targeting of derived MCF7 breast cancer stem cells (CD44(+)/CD24(-/low)): an in vitro study.
    Ahmadipour F; Noordin MI; Mohan S; Arya A; Paydar M; Looi CY; Keong YS; Siyamak EN; Fani S; Firoozi M; Yong CL; Sukari MA; Kamalidehghan B
    Drug Des Devel Ther; 2015; 9():1193-208. PubMed ID: 25759564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydrotanshinone-Induced NOX5 Activation Inhibits Breast Cancer Stem Cell through the ROS/Stat3 Signaling Pathway.
    Kim SL; Choi HS; Kim JH; Jeong DK; Kim KS; Lee DS
    Oxid Med Cell Longev; 2019; 2019():9296439. PubMed ID: 31019654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new mutation-independent approach to cancer therapy: Inhibiting oncogenic RAS and MYC, by targeting mitochondrial biogenesis.
    Ozsvari B; Sotgia F; Lisanti MP
    Aging (Albany NY); 2017 Oct; 9(10):2098-2116. PubMed ID: 29080556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
    Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
    J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling.
    Liu R; Choi HS; Ko YC; Yun BS; Lee DS
    Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are CD44
    Ryspayeva DE; Smolanka II; Dudnichenko АS; Lyashenko AA; Grinevich YA; Gurianov VG; Koshubarova MV; Seleznev AA
    Exp Oncol; 2017 Sep; 39(3):224-228. PubMed ID: 28967636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POMC maintains tumor-initiating properties of tumor tissue-derived long-term-cultured breast cancer stem cells.
    Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
    Int J Cancer; 2017 Jun; 140(11):2517-2525. PubMed ID: 28214331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Myc expression and transcription activity underlies intra-tumoral heterogeneity in triple-negative breast cancer.
    Gupta N; Jung K; Wu C; Alshareef A; Alqahtani H; Damaraju S; Mackey JR; Ghosh S; Sabri S; Abdulkarim BS; Bigras G; Lai R
    Oncotarget; 2017 Apr; 8(17):28101-28115. PubMed ID: 28427212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF drives cancer-initiating stem cells through VEGFR-2/Stat3 signaling to upregulate Myc and Sox2.
    Zhao D; Pan C; Sun J; Gilbert C; Drews-Elger K; Azzam DJ; Picon-Ruiz M; Kim M; Ullmer W; El-Ashry D; Creighton CJ; Slingerland JM
    Oncogene; 2015 Jun; 34(24):3107-19. PubMed ID: 25151964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.